We report two patients who developed atypical skin lesions caused by Curvularia sp. and Pseudallescheria boydii after allogeneic bone marrow transplantation for severe aplastic anemia. The first patient (female, 18-year-old) had multiple hemorrhagic vesicles on day +30 after her second BMT for graft failure. Pseudallescheria boydii was isolated from a skin biopsy. The patient died of respiratory failure probably as a consequence of systemic fungal infection. The second patient (male, 9-yearold) developed an ecthyma gangrenosum-like lesion on his right palm on day +8. Curvularia sp. was isolated from a skin biopsy. Liposomal amphotericin was given to achieve a total dose of 30 mg/kg and followed by oral itraconazole until steroids were discontinued. The infection resolved completely and the patient has remained disease-free. We conclude that emerging fungal organisms such as those described in this report are increasingly recognized in this setting. Early recognition and biopsy of these cutaneous lesions will allow prompt initiation of therapy to prevent systemic infection. Bone Marrow Transplantation (2001) 27, 1311-1313. Keywords: Curvularia sp.; Pseudallescheria boydii; bone marrow transplantation; fungal infection Fungal infections cause significant morbidity and mortality in bone marrow transplant recipients.
Fungal infections cause significant morbidity and mortality in bone marrow transplant recipients. 1 Candida and Aspergillus sp. are the most common fungal pathogens in this setting although new fungal opportunists (hyalohyphomycoses and phaeohyphomycoses) may occasionally be isolated and identified as being responsible for local or systemic infections. 2, 3 The purpose of this report is to describe the clinical manifestations and the mycological findings of two patients after allogeneic BMT who developed atypical skin lesions caused by unusual opportunistic fungi. 
Case reports

Patient 1
An 18-year-old woman diagnosed with hepatitis-associated severe aplastic anemia underwent BMT from her HLAidentical brother. Serologic tests for hepatitis A, B and C virus were negative. Conditioning consisted of CY 200 mg/kg and horse antilymphocyte globulin (PasteurMérieux, Lyon, France) 90 mg/kg. GVHD prophylaxis was a combination of CsA and short-course MTX. On day +5 a tender erythematous nodule was detected on her right leg. The patient was experiencing severe myalgia and flu-like symptoms. Direct examination of the skin biopsy revealed the presence of septate hyphae, so amphotericin B deoxycholate was administered. Fusarium solani was identified in the culture obtained from the skin biopsy. For the first 5 days, the lesion developed into a violet nodule with a necrotic center and then improved gradually leaving a hypopigmented scar. The patient's condition improved gradually. Amphotericin B deoxycholate was replaced by itraconazole 200 mg/day after engraftment and it was continued up to day +90. No recurrence of fungal infection was noted.
However, the patient experienced graft failure 4 months after BMT. A second BMT was performed from another HLA-identical brother after conditioning with TBI 12 Gy and CY 120 mg/kg. CsA and MTX were used as GVHD prophylaxis. Sepsis with Corynebacterium sp. and pericardial effusion complicated the post-transplant course. She was treated with broad-spectrum antibiotics and empirical liposomal amphotericin 2 mg/kg/day up to a total dose of 30 mg/kg. Her condition worsened and she developed cardiac tamponade with the appearance of pleural effusion and lower right lobe pneumonia. On day +18 she developed grade II GVHD of the skin (confirmed histologically) and methylprednisolone was administered. The neutrophil counts were 0.50 × 10 9 /l and 1.0 × 10 9 /l on days +23 and +24, respectively. She underwent pericardial drainage on day +29 and no infectious organism was found. On day +30, multiple hemorrhagic vesicles were detected on both upper and lower limbs. A skin biopsy showed focal epithelial necrosis with scattered septated hyaline fungal filaments in the necrotic area and in skin appendages. On day +33 her condition deteriorated further and she died of respiratory failure. Ten days after her death the culture of the skin lesion yielded Pseudallescheria boydii. Permission for an autopsy was declined by her parents.
Patient 2
A 9-year-old boy diagnosed with severe aplastic anemia underwent BMT from his HLA-identical brother. Before the transplant, he had experienced febrile episodes and neutropenia for 2 months, which were treated with broadspectrum antibiotics and amphotericin B deoxycholate. Conditioning consisted of CY 200 mg/kg and horse antilymphocyte globulin (Pasteur-Mérieux) 90 mg/kg. GVHD prophylaxis was a combination of CsA and short-course MTX. On day +8 two reddish papules appeared on his right forearm. Three days later he became febrile and an erythematous lesion followed by central necrosis (ecthyma gangrenosum-like lesion) was observed on his right palm. Empirically the administration of imipenem, amikacin and amphotericin B deoxycholate was initiated. Histopathologic evaluation of the skin biopsy revealed focal ulceration of the epidermis with extensive hemorrhage and necrosis of the papillary dermis. Branching septate hyphae were seen, and the culture was positive for Curvularia sp. Amphotericin B deoxycholate was replaced by liposomal amphotericin owing to nephrotoxicity, and a total dose of 30 mg/kg was achieved. The neutrophil counts were 0.50 × 10 9 /l and 1.0 × 10 9 /l on days +10 and +14, respectively. Grade II GVHD of the skin (confirmed histologically) developed on day +29 and resolved after treatment with methylprednisolone. Itraconazole 200 mg/day was then continued as maintenance therapy for the duration of steroid treatment. The patient is alive and well 4 years after BMT; there has been no clinical evidence of GVHD and no infectious events have occurred.
Supportive care given to both patients included isolation in a room with HEPA filtered air, total parenteral nutrition, prophylactic acyclovir, oral fluconazole 6 mg/kg from day −7 until myeloid engraftment (neutrophil counts greater than 0.50 × 10 9 /l) or prescription of intravenous amphotericin, whichever occurred first, aerosolised amphotericin 5 mg every 12 h from admission to day +90, weekly IVIG administration 500 mg/kg from day −1 to day +90 and GM-CSF 5 g/kg/day from day +1 until myeloid engraftment.
Discussion
Frequent and prolonged exposure of immunocompromised patients to a variety of environmental conditions has resulted in infections caused by new fungal opportunists. 1, 2 Three diverse groups of fungi are responsible for these infections: hyalohyphomycoses, phaeohyphomycoses and certain yeasts. Pseudallescheria boydii is the heteromorph or sexual state of a cosmopolitan fungus whereas Scedosporium apiospermun is the anamorph or asexual state. 2 In immunocompromised hosts Pseudallescheria boydii can cause sinusitis, pneumonia and endophthalmitis and has a tendency for dissemination and involvement of the central nervous system. [4] [5] [6] [7] Pheohyphomycoses are fungal infections caused by darkly pigmented fungi (colour imparted by melanin in the cell walls). The four genera most frequently encountered in humans are Curvularia, Bipolaris, Exserohilum and Alternaria. 2 Although cases of Curvularia infection in immunocompetent hosts involving the lung, sinuses, endocardium, skin, subcutaneous tissues, liver, spleen and cornea have been described, infections in immunocompromised hosts have been reported only occasionally. 8, 9 The first patient, who had a localized Fusarium infection during her first transplant, developed a second fungal infection caused by Pseudallescheria boydii with multiple hemorrhagic vesicles during the second transplant. A disseminated infection involving the lungs could not be confirmed because autopsy was denied. Curvularia sp. was the organism isolated from the skin lesion of patient 2. He presented with an erythematous lesion followed by central necrosis (ecthyma gangrenosum-like lesion). To the best of our knowledge these two types of skin lesion caused by Curvularia sp. and Pseudallescheria boydii have not yet been reported in bone marrow transplant recipients.
Histopathological findings of these fungi do not permit distinction between the different molds; culture or specific staining of tissue specimens obtained at biopsy are required to avoid delayed or inappropriate medical therapy. 10 In our study a correlation between histopathological findings and cultures was found in every case.
The increased incidence of opportunistic fungal infections seen after BMT is related to some risk factors that have been detected in our patients. They had the antecedent of severe aplastic anemia with prolonged neutropenia, the use of broad-spectrum antibiotics, and immunosuppressive therapy administered to treat GVHD. 1 The empirical use of amphotericin B administered during the first transplant may have selected Pseudallescheria boydii in patient 1.
The overall prognosis remains poor in immunocompromised hosts with these fungal infections. [1] [2] [3] Resection of localized lesions is important for both diagnosis and therapy.
2,3
Pseudallescheria boydii is often resistant to amphotericin B and flucytosine. 2 The use of itraconazole to control infections by this organism has been reported. 5 We did not use itraconazole in patient 1 because cultures were positive for Pseudallescheria boydii only after the patient's death. Curvularia infection is usually treated with amphotericin B but itraconazole, miconazole, flucytosine and ketoconazole have also been used with success. 2, 3 In our patients amphoterin B was given for empiric antifungal coverage until the final characterization of the fungus. Amphoterin B deoxycholate was replaced by liposomal amphotericin owing to nephrotoxicity. Itraconazole 200 mg/day was then continued as maintenance therapy for the duration of the steroid treatment.
Complete resolution of the skin lesions occurred in the patient with localized Curvularia infection. The patient with Pseudallescheria boydii infection and probable dis-semination, died 2 days after the start of the symptoms and before mycological confirmation was obtained.
There was no concrete evidence that the skin was the portal of entry for local or systemic infection in our patients. Notwithstanding, the emergence of these fungi that tend to disseminate and are frequently fatal in immunocompromised hosts requires increased awareness by clinicians and microbiologists.
